DelMar Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Academic Collaborations
    • Management Team
    • Board of Directors
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • Publications
  • Clinical Trials
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Independent Directors
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

DelMar Pharmaceuticals Joins OTCQX

Dec 2, 2014

DelMar Pharmaceuticals' Promising New Data Support the Potential of VAL-083 to Meet Significant Unmet Medical Needs in the Treatment of Glioblastoma Multiforme

Nov 17, 2014

DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 as a Potential New Treatment in Glioblastoma at the Society of Neuro-Oncology Annual Meeting

Nov 14, 2014

DelMar Pharmaceuticals Announces September 30, 2014 Results and Provides Corporate Update

Nov 10, 2014

DelMar Pharmaceuticals Invited to Present New Data on VAL-083 in the Treatment of Glioblastoma Multiforme at the Society for NeuroOncology Annual Meeting

Nov 6, 2014

VAL-083 Demonstrates Promise as a Potential Treatment for Non-small Cell Lung Cancer

Oct 9, 2014

DelMar Pharmaceuticals Announces Presentations at Upcoming Scientific Meetings

Oct 6, 2014

DelMar Pharmaceuticals to Present at the SeeThruEquity Fall Microcap Investor Conference

Sep 4, 2014

DelMar Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent for VAL-083

Sep 3, 2014

DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments

Aug 29, 2014
RSS
  • 1
  • 2
  • 3
© 2019 DelMar Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Legal Information